INTRODUCTION {#s1}
============

In Japan, the number of patients with vertebral compression fracture (VCF) has tended to increase because of the super-aging of society. There are approximately 2 million cases of VCF per year[@r1]^)^, and this fracture causes pain and dysfunction, reduces QOL, and increases the risk of death[@r2], [@r3]^)^. Therefore, future countermeasures against VCF are important.

Patients with VCF also often exhibit sarcopenia, which is defined as a syndrome characterized by a progressive and systemic decrease of skeletal muscle mass and strength, along with physical dysfunction and a risk of death[@r4]^)^. Sarcopenia progresses due to aging, decreased activities, malnutrition, and disease[@r4]^)^. Patients with VCF have significantly decreased muscle mass[@r5], [@r6]^)^, and the prevalence of sarcopenia in these patients is 22.7--43.7%[@r7],[@r8],[@r9]^)^, which is higher than that of other orthopedic disorders[@r9]^)^. Some patients with VCF may also develop anorexia and subsequent malnutrition due to the pain and deformation of the spine after onset of the disease[@r10]^)^, and malnutrition affects the outcome of rehabilitation[@r11], [@r12]^)^. In elderly women with acute VCF, nutritional intake is also associated with ADL[@r13]^)^, andmalnutrition is a significant predictor for mortality after VCF[@r14]^)^. These findings suggest that sarcopenia may be associated with malnutrition in patients with VCF, which may affectfunctional prognosis. However, there are few data available for this relationship.

Therefore, the purpose of this study is to investigate associations among sarcopenia, malnutrition, and ADL in patients with VCF.

PARTICIPANTS AND METHODS {#s2}
========================

A retrospective cohort study was performed in patients aged ≥65 years who were admitted to Tamura Surgical Hospital with VCF from February 2016 to August 2017. During this period, 52 such patients were hospitalized. Patients were excluded if they could not walk before suffering the fracture (5 cases), had missing data (3 cases), had difficulty in communication (4 cases), had a neurological disorder in the lower extremities (2 cases), or were transferred to another hospital due to development of a malignant tumor or a complication (2 cases). Therefore, 36 patients (male: 11, female: 25, age: 83.6 ± 5.5 years, mean ± SD) with VCF were included in the final analysis.

The participants were divided into groups with and without sarcopenia at admission. It was difficult to obtain walking speeds for each participant at hospital admission because some also suffered from lumbar pain. Therefore, evaluation of sarcopenia was performed based on grip strength and calf circumference (CC) at admission ([Fig. 1](#fig_001){ref-type="fig"}Fig. 1.Diagnosis of sarcopenia.VCF: Vertebral compression Fracture; CC: Calf circumference.). Grip strengths of the right and left hands were measured twice each using a Smedley-type hand dynamometer, and the maximum value was recorded. The standard values of the Asian Working Group for Sarcopenia are 26 kg for males and 18 kg for females[@r15]^)^, with a grip strength lower than these values defined as low. The CC was measured using Inser-Tape (Abbott Japan Co., Ltd., Tokyo, Japan) in the maximum bulging area in a supine position with the knee joint bent by 90°. The mean of measurementsfor the right and left leg was calculated. Amean CC ≤30 cm for males and ≤29 cm for females was defined as low, as suggested by Maeda et al[@r16]^)^.

Nutritional status at admission and at discharge was evaluated using the Mini Nutritional Assessment Short Form (MNA-SF)[@r17]^)^, with scores (range 1--14) of ≥12, 8--11, and \<8 points defined as a favorable nutritional status, risk of malnutrition, and malnutrition, respectively. The daily energy intake rate was calculated by a dietician for 7 days after admission by dividing energy intake by energy consumption. Energy obtained from intravenous nutrition and/or nutritional supplements was added to the energy intake. Energy consumption was obtained using the following formula: basal metabolic expenditure calculated with the Harris-Benedict Equation × 1.2 (activity index).

Body weight at admission was obtained from the patient or based on information from their family members. Weight at discharge was measured in a standing position on a scale. Height was measured when the patient became able to take a standing position. Changes in weight and CC during the period from admission to discharge were evaluated as follows:

Weight loss (%)=(weight at admission − weight at discharge) / weight at admission × 100.

CC loss (%)=(CC at admission − CC at discharge) / CC at admission × 100.

ADL at admission and discharge was measured using the Barthel Index (BI). Walking ability before admission, at the start of gait training,and at discharge was evaluated using the Functional Ambulation Category (FAC)[@r18]^)^. Values were classified into 6 levels based on quality of walking, ranging from the assistance-needed level to the highest level. Pain at admission and at discharge was evaluated using the Numerical Rating Scale (NRS) as a score from 0 to 10, indicating no pain to the severest pain. The number of preparatory days beforegait training and the hospitalization days were also recorded.

Histories of the participants are based on hospital medical records. Total protein (TP) and C-reactive protein (CRP) were measured in blood tests at admission. Fractures were classified into each crush injury level based on a plain X-ray examination at admission using the semiquantitative (SQ) method[@r19]^)^, and the number of vertebral fractures was evaluated.

Physical therapy was given to all participants. Because low back pain was strong at admission, physical therapy began with relaxation, range of motion exercise, and resistance training at the bedside. If pain was relieved, treatment was advanced to sitting, standing, ADL, and walking training. The patient wore a corset as needed. Progression of activities was dependent on patient tolerance and stability.

Comparison of the sarcopenia and non-sarcopenia groups was made by unpaired t-test or Mann-Whitney U test after confirming the normality of variables in a χ^2^ test for nominal scales, a Mann-Whitney U test for ordinal scales, and a Shapiro-Wilk test for continuous variables. Weight and CC at admission and at discharge were evaluated by paired t-test, and the number of participants with sarcopenia and/or malnutrition was compared by signed rank test. Spearman rank correlation analysis was used to examine relationships between BI and other items. To identify factors that affected ADL at discharge, stepwise regression analysis was conducted utilizing BI at discharge as the dependent variable. Variables with a significant association with BI in univariate analysis were selected as independent variables. All statistical analyses were performed using SPSS Statistics 23 (IBM), and the significance level was 5%.

The participants were provided with an explanation of the study objectives and measurements. The study was conducted after obtaining approval from the ethical committee of the International University of Health and Welfare (Approval Number: 16-Ig-41).

RESULTS {#s3}
=======

A comparison of the sarcopenia and non-sarcopenia groups is shown in [Table 1](#tbl_001){ref-type="table"}Table 1.Sarcopenia group and non-sarcopenia group outcomesOverallNon-sarcopeniaSarcopenia(n=36)(n=19)(n=17)Basic informationAge (years)83.6 ± 5.584.5 ± 4.882.5 ± 6.2GenderMales (n)1156Females (n)251411Medical histryStroke (n)532Fracture (including other than VCF) (n)20812Heart disease (n)853Respiratory disease (n)312Dementia (n)523Diabetes (n)321Grade of SQ method3 \[1--3\]3 \[1--3\]3 \[2--3\]Number of VCF (piece)2.2 ± 0.61.9 ± 1.02.5 ± 0.9FAC before hospitalization4 \[4--5\]5 \[4--5\]4 \[4--5\]At admissionBI (score)21.5 ± 10.521.8 ± 12.821.2 ± 7.6Hight (cm)152.2 ± 9.2152.8 ± 7.3151.5 ± 11.2Weight (kg)47.4 ± 9.654.1 ± 6.939.8 ± 5.7\*\*BMI (kg/m^2^)20.5 ± 3.823.2 ± 2.617.4 ± 2.4\*\*Grip strength (kg)15.6 ± 7.618.7 ± 8.512.2 ± 4.7\*\*CC (cm)29.0 ± 3.031.2 ± 1.726.5 ± 2.0\*\*MNA-SF (score)6.3 ± 2.27.7 ± 1.54.7 ± 1.8\*\*Malnutrition (n)22616\*\*At risk of malnutrition (n)14131\*\*Well nourished000TP (g/dl)6.7 ± 0.76.7 ± 0.66.8 ± 0.8CRP (mg/dl)1.8 ± 1.81.6 ± 1.62.0 ± 2.1Energy intake rates1.0 ± 0.31.0 ± 0.31.0 ± 0.2Pain8.0 ± 1.58.2 ± 1.67.8 ± 1.5ProcessThe days required to begin gait training (days)12.0 ± 6.412.0 ± 7.111.9 ± 5.7FAC at the start of gait training3 \[1--4\]3 \[1--4\]2 \[1--3\]\*\*At dischargeBI (score)76.9 ± 18.184.5 ± 13.868.5 ± 19.0\*\*FAC4 \[1--5\]4 \[3--5\]4 \[1--4\]\*Weight (kg)45.0 ± 8.350.1 ± 5.638.3 ± 5.3\*\*BMI (kg/m^2^)19.4 ± 3.521.9 ± 2.516.7 ± 2.3\*\*Grip strength (kg)15.7 ± 7.818.9 ± 8.912.1 ± 4.1\*\*CC(cm)28.3 ± 2.930.4 ± 1.925.9 ± 1.7\*\*MNA-SF (score)6.7 ± 2.47.8 ± 2.25.3 ± 1.8\*\*Malnutrition (n)24915\*\*At risk of malnutrition (n)12102\*\*Well nourished000Pain3.0 ± 2.62.8 ± 1.93.2 ± 2.6Weight loss (%)4.7 ± 5.25.5 ± 6.03.8 ± 4.3CC loss (%)2.3 ± 3.32.6 ± 3.41.9 ± 3.2The number of hospitalization days (days)33.8 ± 14.032.5 ± 12.035.3 ± 16.3Mean ± SD, median \[range\].VCF: Vertebral Compression Fracture; SQ: Semiquantitative Method; FAC: Functional Ambulation Categories; BMI: Body Mass Index; CC: Calf circumference; BI: Barthel Index; MNA-SF: Mini Nutritional Assessment-Short Form; TP: Total Protein; CRP: C-reactive protein.Comparison of non-sarcopenia group and sarcopenia group. Continuous variables: unpaired t-test; Mann-Whitney U-test. Categorical variables: χ^2^ test. \*p\<0.05, \*\*p\<0.01.. Of the 36 participants, 17 (47.2%) had sarcopenia and 22 (61.1%) had malnutrition. Compared to the non-sarcopenia group, the sarcopenia group had a significantly lower BI and walking ability at discharge, and had a significantly lower BMI and MNA-SF at both admission and discharge. Changes in sarcopenia and malnutrition from admission to discharge are shown in [Table 2](#tbl_002){ref-type="table"}Table 2.Changes in sarcopenia and malnutrition at admission and dischargeAt admissionAt dischargeWeight (kg)47.4 ± 9.645.0 ± 8.3\*BMI (kg/m^2^)20.5 ± 3.819.4 ± 3.5\*Weight loss (%)4.7 ± 5.2CC (cm)29.0 ± 3.028.3 ± 2.9\*CC loss (%)2.3 ± 3.3Sarcopenia (n, %)17 (47.2)20 (55.6)Malnutrition (n, %)22 (61.1)24 (66.7)Mean ± SD.BMI: Body Mass Index; CC: Calf Circumference. Comparison of admission and discharge. Continuous variables: unpaired t-test. Categorical variables: χ^2^ test. \*p\<0.05.. At discharge, there were significant decreases in weight and CC in all participants, and 20 (55.6%) had sarcopenia and 24 (66.7%) had malnutrition, showing a tendency for these conditions to increase. Spearman rank correlations for BI at discharge are shown in [Table 3](#tbl_003){ref-type="table"}Table 3.Spearman rank correlations for Barthel Index at dischargeVariablesrAge−0.384\*Gender−0.047BMI0.377\*Presence of sarcopenia at admission−0.460\*\*MNA-SF at admission0.650\*\*TP−0.013CRP−0.072Energy intake rates0.232Pain0.148Grade of SQ method−0.005Number of vertebral compression fractures−0.273The days required to begin gait training−0.134Presence of sarcopenia at discharge−0.434\*\*MNA-SF at discharge0.595\*\*Weight loss−0.450\*\*CC loss−0.347\*Stroke−0.184Fracture (including other than VCF)0.041Heart disease0.062Respiratory disease0.069Dementia−0.234Diabetes−0.244BMI: Body Mass Index; MNA-SF: Mini Nutritional Assessment-Short Form; TP: Total Protein; CRP: C-reactive protein; BI: Barthel Index; SQ: Semiquantitative Method; CC: Calf Circumference. \*p\<0.05, \*\*p\<0.01.. BI at discharge had significant correlations with age, BMI, presence of sarcopenia, MNA-SF scores at admission and at discharge, FAC at the start of gait training and at discharge, weight loss, and CC loss (p\<0.05). The results of multiple linear regression analysis for BI at discharge are shown in [Table 4](#tbl_004){ref-type="table"}Table 4.Multiple linear regression analysis for Barthel Index at dischargeVariablesUnstandardizedStandardized βp-value95% CIBSELower bound to Upper bound(Constant)115.30126.946\<0.00160.414 to 170.189MNA-SF at hospitalization5.4860.7660.669\<0.0013.925 to 7.047CC loss−2.3750.549−0.423\<0.001−3.476 to −1.238Age−0.8070.324−0.2460.018−1.468 to −0.147Adjusted R^2^: 0.695, p\<0.001.CI: Confidence Interval; MNA-SF: Mini Nutritional Assessment-Short Form; CC: Calf Circumference.. MNA-SF score at admission, CC loss, and age emerged as independent factors affecting BI at discharge.

DISCUSSION {#s4}
==========

This study of the relationships among sarcopenia, nutritional status and ADL in patients with VCF resulted in three findings. First, patients with sarcopenia had poor nutritional status and low ADL at discharge. Second, weight loss and muscle atrophy were found in many of the patients at discharge. Third, malnutrition, CC loss, and age are associated with ADL at discharge.

Sarcopenia and malnutrition were present at rates of 47.2% and 61.1% in the patients in this study. A prevalence of sarcopenia in patients with VCF of 22.7--43.7% has been reported in previous studies[@r7],[@r8],[@r9]^)^. The higher rate in the current study might be due to the higher age of the participants and to the inclusion of more participants with multiple VCF. There are few previous data on the rate of malnutrition in patients with VCF, but the results of this study suggest that such patients are highly likely to develop malnutrition as a complication. In addition, nutritional status was poorer in patients with sarcopenia. The concomitant development of osteoporosis and sarcopenia due to aging and malnutrition is thought to cause VCF by decreasing physical function and increasing fall and bone vulnerability[@r20]^)^. Furthermore, patients with sarcopenia had lower ADL at discharge, and univariate analysis showed relationships of lower ADL at discharge with sarcopenia and malnutrition. Previous studies have suggested that elderly inpatients with malnutrition and/or sarcopenia have lower ADL, and we obtained similar results[@r21], [@r22]^)^. Therefore, sarcopenia and malnutrition are risk factors for low ADL in patients with VCF, and both of these factors should be assessed.

In this study, the losses of weight and CC found in many participants at discharge were closely related to the increases in sarcopenia from 47.2% at admission to 55.6% at discharge and in malnutrition from 61.1% at admission to 66.7% at discharge. A previous study found development of sarcopenia in 14.7% of inpatients[@r23]^)^, and this may be related to nutritional status and the number of days of bed rest[@r23]^)^. Patients with VCF are often forced to have bed rest due to pain, and in the current study, the mean period required for commencement of gait training was 12.0 days in all the participants. Therefore, malnutrition, bed rest, and lowered activity are all considered to be causes of CC loss.

The findings of this study showing that malnutrition, CC loss, and age affect ADL at discharge indicate the importance of nutritional management during rehabilitation to improve nutritional status and sarcopenia. This result also shows the importance of working with managerial dieticians to evaluate nutritional status and muscle mass from the point of hospital admission. In recent years, it has been suggested that a combination of rehabilitation and appropriate nutritional management are useful for improvement of sarcopenia and malnutrition[@r11]^)^. Even during bed rest, patients should be provided with active resistance training at the bedside and neuromuscular electrical stimulation therapy[@r24], [@r25]^)^ to prevent muscle atrophy.

In this study, we utilized grip strength and CC to evaluate sarcopenia. In general, measurement of muscle mass can be made using bioelectrical impedance analysis (BIA) and dual-energy X-ray absorptiometry (DEXA) in evaluation of sarcopenia[@r4], [@r15]^)^. However, few facilities have such devices available. For measurement of physical function, walking speed can be used; however, it is often difficult to measure the walking speed of inpatients with pain in an acute phase or during bed rest, as was the case for some patients in this study. A previous study found difficulty with evaluation of walking speed in 40.2% of elderly inpatients due to medical problems[@r26]^)^. Previous results[@r21], [@r27]^)^ and those in this study suggest that sarcopenia can be adequately evaluated using grip strength and CC, and that this evaluation is useful for prognostic prediction of ADL and evaluation of nutritional status. It is also important to begin regular evaluation of grip strength and the circumferences of extremities using a simple method at admission.

The limitations of this study include the small number of participants at a single facility. Further studies are needed with more participants in multiple facilities, including examination of an intervention using a combination of nutritional management and rehabilitation for patients with VCF. Within these limitations, we conclude that many patients with VCF exhibit sarcopenia and malnutrition, and that these conditions may exacerbate during hospitalization. These changes may affect ADL, which suggests the importance of rehabilitation nutrition management for patients with VCF.
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